Publikation

Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores

Wissenschaftlicher Artikel/Review - 02.01.2019

Gargiulo Piera, Pignata Sandro, Berardi Simona, Glimelius Bengt, Scheithauer Werner, Ruhstaller Thomas, Bodoky György, Herrmann Richard, Dietrich Daniel, Brauchli Peter